Neat Little Guide — 9 minutes
Trisomy Disorders
What is trisomy?
Trisomy is a genetic condition characterized by the presence of three copies of a chromosome instead of two. The extra chromosome can disrupt development of the fetus. This disruption occurs during cell division, and the chances of it happening increase with the mother’s age. Although trisomy is a genetic condition, it is generally not hereditary.
Trisomy can occur in all chromosomes but trisomies 13, 18 and 21 are the best known and most common. Each of these trisomies is linked to specific characteristics and certain health problems.
Trisomy 21, the most common, is characterized by variable intellectual disability, motor disorders, language delay, distinctive facial features and sometimes health problems such as a heart defect. Those affected can lead active and fulfilling lives if they receive the right support. Trisomy 21 can also occasionally result in miscarriage.
This form is rarer and more serious. Many pregnancies involving trisomy 18 end in miscarriage. Babies affected by trisomy 18 often have severe defects of the heart, kidneys and other organs. Most children affected do not survive beyond their first year, although some may live longer with intensive care.
Equally rare and serious, trisomy 13 causes severe defects of the brain, heart and other organs. Children with this syndrome have a very short life expectancy, often less than a year, due to major medical complications, but some can live longer. As with trisomy 18, many pregnancies involving trisomy 13 end in miscarriage.
What are the risk factors?
Trisomies generally happen at random, but are nevertheless associated with older maternal age. The later the pregnancy, the greater the chance the fetus will be affected by trisomy (CUCKLE, H.S., et al., 1987).
How to get tested during pregnancy?
Screening tests during pregnancy allow us to identify chromosomal abnormalities such as trisomies. Prenatal screening is available as part of a pregnancy follow-up, but these procedures are not routine. You can choose to undergo them or not, depending on your situation, wishes or personal values. The decision is entirely yours.
Two distinct screening methods are available, each of which can be supplemented by an ultrasound with a nuchal translucency scan. For each of these screenings, an invasive diagnostic test is required if there is a high risk of trisomy.
The biochemical test involves a blood test during the pregnancy. By combining the pregnant woman’s age and the results of her blood test, we can determine the probability of the baby having trisomy 21 or 18 (at this stage, we cannot distinguish between trisomies 18 and 13). If the probability is low, no more screening is needed. If the probability is high, the next step involves an invasive diagnostic test.
As a result, keep in mind that a biochemical test indicating a high probability does not necessarily mean the baby will be born with trisomy 21 or 18.
With ultrasound
The biochemical test can be done with or without an ultrasound. If a healthcare professional recommends it, you may undergo an ultrasound in addition to the biochemical test between the 11th and 13th weeks of pregnancy. The ultrasound allows us to measure nuchal translucency, i.e., the space between the skin of the neck and the spine of the fetus. A nuchal translucency measurement above the 95th percentile (taking maternal and gestational ages into account) indicates a higher probability of trisomy 21, malformations of the fetus or other chromosomal anomalies.
Along with detecting trisomies 21 and 18, a genomic test can also reveal trisomy 13 and other genetic anomalies, such as those involving sex chromosomes. Compared to biochemical testing, NIPT is more sensitive and accurate (more specific), meaning you can limit the invasive tests to those that are truly required.
A non-invasive prenatal genomic test analyzes fragments of placental DNA from a blood sample drawn from the pregnant woman. The procedure is, therefore, safe for both mother and fetus. Testing is available as early as the 10th week of pregnancy and screens for trisomies 21, 18 and 13. If the mother so desires, the test can also identify the baby’s sex and detect sex chromosome aneuploidy (XXX, XXY, XYYY, X).
Simple, safe and reliable, learn more about our prenatal fetal DNA screening tests available near you.
If the chosen screening test shows a high probability of trisomy 21, 18 or 13 (if NIPT was used), the healthcare professional will recommend a diagnostic test. This test helps confirm whether or not the baby is affected by trisomy or a sex chromosome anomaly. However, diagnostic testing is invasive, involving certain risks of complications that can sometimes lead to miscarriage. For this reason, the test is not offered from the beginning.
Two methods are available for obtaining the sample required for the diagnostic test: chorionic biopsy and amniocentesis. The healthcare professional will guide the pregnant woman based on her personal situation.
Amniocentesis
Amniocentesis consists of inserting a fine needle into the abdomen to collect a small amount of the amniotic fluid surrounding the baby in the uterus. This fluid contains fetal cells that can be analyzed for chromosomes. This test can be performed as early as the 15th week of pregnancy.
Chorionic villus biopsy
Chorionic villus biopsy consists of collecting a small sample of placenta, known as the chorionic villi. This ultrasound-guided procedure can be performed via the abdomen or the vagina. It is generally done between the 11th and 14th weeks of pregnancy. In a minority of cases, an amniocentesis may still be necessary following a chorionic biopsy.
Once the tests are completed, you may be faced with the difficult choice of continuing or terminating the pregnancy. In these circumstances, do not hesitate to discuss the matter with your healthcare professional or the people around you. Support groups are also available in various regions of Quebec. You can contact your local CLSC for more information.
Keep in mind that this is not a routine examination. The decision whether or not to undergo these tests is entirely up to you. If you have any questions, feel free to discuss them with your healthcare professional.
Are postnatal tests available to screen for trisomy?
Yes, tests can be done following childbirth to screen the baby for trisomy.
The pediatrician can detect typical physical signs of trisomy during a clinical examination. For trisomy 21, for example, these signs may include specific facial features, hypotonia (low muscle tone) and abnormalities in the hands and feet.
However, while clinical examination may suggest trisomy, it is not sufficient for a definitive diagnosis.
A karyotype is a test to analyze the baby’s chromosomes. It is performed on a blood sample. A karyotype can accurately confirm the presence of trisomy 21, 18 or 13 by revealing the extra copy of the chromosome.
This test, also known as “FISH,” offers a number of several additional advantages compared to karyotyping, such as identifying duplications or deletions of small portions of chromosomes. It is also done on a blood sample. This means that CMA can detect subtle chromosomal abnormalities that may not be visible on a standard karyotype.
To sum it up, a clinical examination after birth may initially suggest the presence of trisomy, but genetic tests such as a karyotype or chromosomal microarray analysis are needed to confirm the diagnosis. These tests do not present any significant risk for the baby and can accurately determine the presence and type of trisomy, thereby ensuring appropriate care for the baby and proper support for the family.
How to care for a child with trisomy 21?
The arrival of a child with trisomy can lead to a period of questioning and require adjustments. The Canadian Down Syndrome Society offers a wealth of resources for new parents who are expecting or have recently had a child with Down syndrome (trisomy 21).
Here are a few ways to address the needs of a child with Down syndrome:
- Find out more about your child’s situation, so that you can identify their needs. You can visit Facebook groups for parents of children with trisomy. A number of support associations also exist in the province, such as, the Quebec Intellectual Disability Society [AISQ] and the Regroupement pour la Trisomie 21 [RT21]. Your healthcare professional can direct you to various resources.
- Share what you learn with family and friends, so that they can,too, better understand your child and offer the right support.
- Plan regular medical follow-ups to monitor and treat any health complications.
- Maintain a stable routine, so that the child feels safe and secure, and make sure your home is adapted to the child’s needs, for example in terms of mobility assistance.
- Foster the child’s social and emotional development through group activities and adapted play activities that stimulate sensory and motor development.
- Include the child in the various spheres of social life, to help them develop emotional relationships, fulfill their potential and live as independently as possible.
Above all, it is important to be there for the child, show patience so that they can develop at their own pace, and do not hesitate to ask for additional help and support.
Insist on the reliability of a non-invasive prenatal genomic test
Simple, safe and reliable, prescription prenatal testing is available at our Biron service centres.